2019
DOI: 10.1016/j.humpath.2018.08.014
|View full text |Cite
|
Sign up to set email alerts
|

Overexpression of RCN1 correlates with poor prognosis and progression in non–small cell lung cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
33
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(36 citation statements)
references
References 15 publications
3
33
0
Order By: Relevance
“…RCN, which localized in the ER, was proven to be involved in the regulation of normal behavior and function of cells, and the RCN up-regulation may also participate in tumorigenesis, tumor invasion, and drug resistance [20]. A purposeful study confirmed that the up-regulated RCN1 was correlated with the poor prognosis and progression of nonsmall cell lung cancer [11]. ADM appears to be an effective and highly sensitive drug against NPC cells [21].…”
Section: Discussionmentioning
confidence: 93%
See 1 more Smart Citation
“…RCN, which localized in the ER, was proven to be involved in the regulation of normal behavior and function of cells, and the RCN up-regulation may also participate in tumorigenesis, tumor invasion, and drug resistance [20]. A purposeful study confirmed that the up-regulated RCN1 was correlated with the poor prognosis and progression of nonsmall cell lung cancer [11]. ADM appears to be an effective and highly sensitive drug against NPC cells [21].…”
Section: Discussionmentioning
confidence: 93%
“…The capability of cell reaction to ER stress-mediated dysregulation is of great importance for the cell survival, because chronic or unresolved ER stress may lead to apoptosis [10]. Abnormal expression of RCN1 protein is shown to participate in multifarious diseases, including cancers, and the highly expressed RCN1 has been proved to be situated in multiple types of cancers, such as breast cancer, liver cancer, kidney cancer, as well as colorectal cancer [11]. Intriguingly, RCN1 knockdown has demonstrated to promote apoptosis and necroptosis in prostate cancer cells [12].…”
Section: Introductionmentioning
confidence: 99%
“…The differential expression of RCN1 is correlated with cancer. RCN1 overexpression has been observed in invasive breast cancer cells (26), lung cancer cells (27), colorectal cancer cells (24), gastric cancer cells (28), liver cancer cells (29), prostate cancer cells (30), and kidney cancer (31), suggesting a role for RCN1 in tumorigenesis and invasion.…”
Section: Resultsmentioning
confidence: 99%
“…Of the 34 significantly differentially expressed Ψ-lnc-parent gene pairs, 25 parent genes were described in cancer. This includes lung cancer associated genes like CS , which affects tumor drug response, as well as RCN1 , which is associated with poor prognosis and tumor progression in lung cancer (Chen et al, 2014, 2018).…”
Section: Resultsmentioning
confidence: 99%